Navigation Links
New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients
Date:10/26/2009

SAN DIEGO, Oct. 26 /PRNewswire/ -- New data from an open-label extension study evaluating the long-term safety and efficacy of CIMZIA® (certolizumab pegol) in moderate to severe Crohn's disease patients demonstrate that 82 percent of patients actively treated with CIMZIA - the only PEGylated anti-TNF-alpha (Tumor Necrosis Factor alpha) - remained in long-term remission without dose escalation up to 3.5 years. In a separate analysis, CIMZIA significantly improved patients' symptoms as early as day 8 as reported in a post-hoc responder analysis of PRECiSE 2, the original double-blind placebo controlled study. These data from PRECiSE 2 and the open-label extension PRECiSE 3 studies are being presented this week at the American College of Gastroenterology (ACG) Annual Meeting in San Diego, Calif.

CIMZIA is indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.

"These data further demonstrate that treatment with a stable dose of CIMZIA enables patients with Crohn's disease to have sustained symptom relief," said study investigator Gary R. Lichtenstein, M.D., Director, Inflammatory Bowel Disease Program, University of Pennsylvania in Philadelphia. "Long-term relief and control of symptoms are vital to helping Crohn's patients manage their disease."

At the start of the open-label extension study, PRECiSE 3, 75 percent of CIMZIA-treated patients (105 out of 141 patients who continued in PRECiSE 3) were in clinical remission. Eighty-two percent of patients who continued in the long-term extension trial on active treatment maintained remission for up to 3.5 years based upon responder analysis. Disease activity was measured by the Harvey-Bradshaw Index (HBI), which tallies the incidence of five clinical items, including general well-being, abdominal pain and number of liq
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
2. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
3. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
4. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
5. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
6. e-Zassi.com Provides Industry With Online U.S. FDA Regulatory Calculator for Rapid Medical Device Technology Assessment
7. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
8. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
9. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
10. Young Innovations, Inc. Provides Third Quarter Conference Call Details
11. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Memorial Hermann Health System and The ... a new partnership to provide a new level of specialized ... in the greater Houston area. ... exclusive provider of professional breast radiology services for five of ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... 2014 The spinal column is one of the ... carried to and from the brain through the column control ... Injury or ailment here can be life altering, and leave ... control over their body. Though back injury and disease can ... are more options available to make things better than ever ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... Inc. (Nasdaq: NLTX ), a company focused on ... announced its second quarter financial results for 2010. ... Nile reported a net loss of approximately $1.5 million, or ... $2.5 million, or $0.10 per share, during the second quarter ...
... FRANCISCO, Calif., Aug. 16 Titan Pharmaceuticals, Inc. (OTC Bulletin ... the second quarter ended June 30, 2010. Total ... consisting primarily of grant and royalty revenues. Grant revenue from ... Phase 3 clinical study of Probuphine® was approximately $1.29 million, ...
Cached Medicine Technology:Nile Therapeutics Reports 2010 Second Quarter Financial Results 2Nile Therapeutics Reports 2010 Second Quarter Financial Results 3Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 2Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 3Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 4Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 5
(Date:8/21/2014)... (Boston) African American women born at a low ... higher risk for developing type 2 diabetes. The findings, ... in part the higher occurrence of type 2 diabetes ... of low birth weight. , Researchers from Boston University,s ... in the Black Women,s Health Study over the course ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Not only is eating ... save them hundreds of health-care dollars a year, a new ... professor of public health sciences at Wake Forest Baptist Medical ... and obese type 2 diabetes patients. Participants ... assigned to either an intensive "lifestyle change program" focused on ...
(Date:8/21/2014)... By Dennis Thompson ... (HealthDay News) -- A combination of therapy and antidepressants ... depression, a new study reports. Four out of ... two years experienced full recovery when treated with cognitive ... other hand, the combination didn,t work much better than ...
(Date:8/21/2014)... 2014 A new study published this ... in disability associated with speech problems from 2001-02 to ... 15% increase in disability associated with hearing problems. The ... numbers of children who are experiencing communication disorders, according ... , On a broader level, the new study, ...
(Date:8/21/2014)... physicians in rural communities do not routinely screen ... Penn State medical and public health researchers. Rural ... limited resources if they seek help., "Rural health ... said Jennifer S. McCall-Hosenfeld, a primary care physician ... sciences, Penn State College of Medicine. "However, in ...
Breaking Medicine News(10 mins):Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2
... Insurance,Leaders, Inc. (Amex: NAO ), today announced that ... NAO entitled to vote at the annual meeting of,stockholders ... business,combination, as presented in the NAO proxy statement dated ... to complete its proposed acquisition of the,insurance businesses of ...
... Site With Expanded Resources for Individuals With,Autism ... March 25 Danya,International, Inc. (Danya), a ... has acquired AutismOnline.org, a trusted,resource for individuals ... links parents and caregivers to support, research, ...
... (Mo.) issued the following statement today after the Social,Security ... Security and Medicare will deplete their respective trust funds ... solemn reminder that we do not have time for,further ... with the fiscal,emergency Social Security and Medicare are facing., ...
... risk of both recurrence and new malignancies surfaced , , ... more grim news concerning women and hormone replacement therapy: ... developing breast cancer while taking the therapy, breast cancer ... of a recurrence or a new malignancy. , "This ...
... Harvard-led team,s findings to be published in the American ... study scheduled,for April publication in the American Journal of ... the University of Michigan found,that women who ate the ... trimester of their pregnancies delivered children with the highest,scores ...
... It,s the time of year when more,than 1.5 million ... up the sun and drink large quantities of alcohol. Students ... as much as,those who stay home with parents or relatives, ... Journal of Studies on Alcohol and Drugs., Instead of ...
Cached Medicine News:Health News:AutismOnline.org Partners With Leading Health Communications Firm for Support 2Health News:HRT Raises Recurrence Risk Among Breast Cancer Survivors 2Health News:Study: Pregnant Women Who Eat More Fish, Including Canned Tuna, Have Smarter Children 2Health News:It's Spring Break: How Much Does Heavy Drinking Affect Your Body? 2
... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
... Fujinon's therapeutic fiberoptic bronchoscopes ... operating channel with a ... large channel allows for ... passage of cytology brushes. ...
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Large, bright images from a bronchoscope designed for routine examination and treatment....
Medicine Products: